img

Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Insights, Forecast to 2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Insights, Forecast to 2034

Nonsteroidal anti-inflammatory drugs (NSAIDs) are a drug class that reduce pain, decrease fever, prevent blood clots and, in higher doses, decrease inflammation. Side effects depend on the specific drug, but largely include an increased risk of gastrointestinal ulcers and bleeds, heart attack and kidney disease.
Market Analysis and InsightsGlobal Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market
Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) market is expected to reach to US$ million in 2023, with a positive growth of %, compared with US$ million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) industry is evaluated to reach US$ million in 2033. The CAGR will be % during 2023 to 2033.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers
This report presents an overview of global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


Roche (Genentech)
Amgen
B-MS
Merck
Pfizer
Novartis
Eli Lilly and Company
Johnson & Johnson
GSK
Sanofi
Boehringer Ingelheim
Zhejiang Jiuzhou Pharmaceutical
Segment by Type
Aspirin
Ibuprofen
Naproxen
Celecoxib
Others

Segment by Application


Drug Store
Hospital Pharmacies
Online
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) introduction, etc. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
Chapter 13Methodology and Data Sources adopted by MRAResearch

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth Rate by Type, 2018 VS 2022 VS 2033
1.2.2 Aspirin
1.2.3 Ibuprofen
1.2.4 Naproxen
1.2.5 Celecoxib
1.2.6 Others
1.3 Market by Application
1.3.1 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth Rate by Application, 2018 VS 2022 VS 2033
1.3.2 Drug Store
1.3.3 Hospital Pharmacies
1.3.4 Online
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Perspective (2018-2033)
2.2 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Growth Trends by Region
2.2.1 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Historic Market Size by Region (2018-2023)
2.2.3 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Forecasted Market Size by Region (2024-2033)
2.3 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Dynamics
2.3.1 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Industry Trends
2.3.2 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Drivers
2.3.3 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Challenges
2.3.4 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) by Players
3.1.1 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Players (2018-2023)
3.1.2 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Players (2018-2023)
3.2 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Concentration Ratio
3.4.1 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue in 2022
3.5 Global Key Players of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Head office and Area Served
3.6 Global Key Players of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Product and Application
3.7 Global Key Players of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Breakdown Data by Type
4.1 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Historic Market Size by Type (2018-2023)
4.2 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Forecasted Market Size by Type (2024-2033)
5 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Breakdown Data by Application
5.1 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Historic Market Size by Application (2018-2023)
5.2 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (2018-2033)
6.2 North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type
6.2.1 North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2018-2023)
6.2.2 North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2024-2033)
6.2.3 North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Type (2018-2033)
6.3 North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application
6.3.1 North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2018-2023)
6.3.2 North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2024-2033)
6.3.3 North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Application (2018-2033)
6.4 North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country
6.4.1 North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country: 2018 VS 2022 VS 2033
6.4.2 North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2018-2023)
6.4.3 North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2024-2033)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (2018-2033)
7.2 Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type
7.2.1 Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2018-2023)
7.2.2 Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2024-2033)
7.2.3 Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Type (2018-2033)
7.3 Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application
7.3.1 Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2018-2023)
7.3.2 Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2024-2033)
7.3.3 Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Application (2018-2033)
7.4 Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country
7.4.1 Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country: 2018 VS 2022 VS 2033
7.4.2 Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2018-2023)
7.4.3 Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2024-2033)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (2018-2033)
8.2 China Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type
8.2.1 China Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2018-2023)
8.2.2 China Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2024-2033)
8.2.3 China Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Type (2018-2033)
8.3 China Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application
8.3.1 China Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2018-2023)
8.3.2 China Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2024-2033)
8.3.3 China Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Application (2018-2033)
9 Asia (excluding China)
9.1 Asia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (2018-2033)
9.2 Asia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type
9.2.1 Asia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2018-2023)
9.2.2 Asia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2024-2033)
9.2.3 Asia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Type (2018-2033)
9.3 Asia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application
9.3.1 Asia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2018-2023)
9.3.2 Asia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2024-2033)
9.3.3 Asia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Application (2018-2033)
9.4 Asia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Region
9.4.1 Asia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Region: 2018 VS 2022 VS 2033
9.4.2 Asia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Region (2018-2023)
9.4.3 Asia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Region (2024-2033)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (2018-2033)
10.2 Middle East, Africa, and Latin America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type
10.2.1 Middle East, Africa, and Latin America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2024-2033)
10.2.3 Middle East, Africa, and Latin America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Type (2018-2033)
10.3 Middle East, Africa, and Latin America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application
10.3.1 Middle East, Africa, and Latin America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2024-2033)
10.3.3 Middle East, Africa, and Latin America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Application (2018-2033)
10.4 Middle East, Africa, and Latin America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country
10.4.1 Middle East, Africa, and Latin America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country: 2018 VS 2022 VS 2033
10.4.2 Middle East, Africa, and Latin America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2024-2033)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Roche (Genentech)
11.1.1 Roche (Genentech) Company Details
11.1.2 Roche (Genentech) Business Overview
11.1.3 Roche (Genentech) Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
11.1.4 Roche (Genentech) Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2018-2023)
11.1.5 Roche (Genentech) Recent Developments
11.2 Amgen
11.2.1 Amgen Company Details
11.2.2 Amgen Business Overview
11.2.3 Amgen Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
11.2.4 Amgen Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2018-2023)
11.2.5 Amgen Recent Developments
11.3 B-MS
11.3.1 B-MS Company Details
11.3.2 B-MS Business Overview
11.3.3 B-MS Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
11.3.4 B-MS Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2018-2023)
11.3.5 B-MS Recent Developments
11.4 Merck
11.4.1 Merck Company Details
11.4.2 Merck Business Overview
11.4.3 Merck Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
11.4.4 Merck Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2018-2023)
11.4.5 Merck Recent Developments
11.5 Pfizer
11.5.1 Pfizer Company Details
11.5.2 Pfizer Business Overview
11.5.3 Pfizer Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
11.5.4 Pfizer Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2018-2023)
11.5.5 Pfizer Recent Developments
11.6 Novartis
11.6.1 Novartis Company Details
11.6.2 Novartis Business Overview
11.6.3 Novartis Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
11.6.4 Novartis Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2018-2023)
11.6.5 Novartis Recent Developments
11.7 Eli Lilly and Company
11.7.1 Eli Lilly and Company Company Details
11.7.2 Eli Lilly and Company Business Overview
11.7.3 Eli Lilly and Company Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
11.7.4 Eli Lilly and Company Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2018-2023)
11.7.5 Eli Lilly and Company Recent Developments
11.8 Johnson & Johnson
11.8.1 Johnson & Johnson Company Details
11.8.2 Johnson & Johnson Business Overview
11.8.3 Johnson & Johnson Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
11.8.4 Johnson & Johnson Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2018-2023)
11.8.5 Johnson & Johnson Recent Developments
11.9 GSK
11.9.1 GSK Company Details
11.9.2 GSK Business Overview
11.9.3 GSK Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
11.9.4 GSK Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2018-2023)
11.9.5 GSK Recent Developments
11.10 Sanofi
11.10.1 Sanofi Company Details
11.10.2 Sanofi Business Overview
11.10.3 Sanofi Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
11.10.4 Sanofi Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2018-2023)
11.10.5 Sanofi Recent Developments
11.11 Boehringer Ingelheim
11.11.1 Boehringer Ingelheim Company Details
11.11.2 Boehringer Ingelheim Business Overview
11.11.3 Boehringer Ingelheim Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
11.11.4 Boehringer Ingelheim Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2018-2023)
11.11.5 Boehringer Ingelheim Recent Developments
11.12 Zhejiang Jiuzhou Pharmaceutical
11.12.1 Zhejiang Jiuzhou Pharmaceutical Company Details
11.12.2 Zhejiang Jiuzhou Pharmaceutical Business Overview
11.12.3 Zhejiang Jiuzhou Pharmaceutical Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
11.12.4 Zhejiang Jiuzhou Pharmaceutical Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2018-2023)
11.12.5 Zhejiang Jiuzhou Pharmaceutical Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2033
Table 2. Key Players of Aspirin
Table 3. Key Players of Ibuprofen
Table 4. Key Players of Naproxen
Table 5. Key Players of Celecoxib
Table 6. Key Players of Others
Table 7. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2033
Table 8. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 9. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Region (2018-2023) & (US$ Million)
Table 10. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Region (2018-2023)
Table 11. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 12. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Region (2024-2033)
Table 13. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Trends
Table 14. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Drivers
Table 15. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Challenges
Table 16. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Restraints
Table 17. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Players (2018-2023) & (US$ Million)
Table 18. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Share by Players (2018-2023)
Table 19. Global Top Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) as of 2022)
Table 20. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Industry Ranking 2021 VS 2022 VS 2023
Table 21. Global 5 Largest Players Market Share by Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (CR5 and HHI) & (2018-2023)
Table 22. Global Key Players of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Headquarters and Area Served
Table 23. Global Key Players of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Product and Application
Table 24. Global Key Players of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Product and Application
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2018-2023) & (US$ Million)
Table 27. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Type (2018-2023)
Table 28. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 29. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Type (2024-2033)
Table 30. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2018-2023) & (US$ Million)
Table 31. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Share by Application (2018-2023)
Table 32. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 33. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Share by Application (2024-2033)
Table 34. North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2018-2023) & (US$ Million)
Table 35. North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2024-2033) & (US$ Million)
Table 36. North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2018-2023) & (US$ Million)
Table 37. North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2024-2033) & (US$ Million)
Table 38. North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 39. North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2018-2023) & (US$ Million)
Table 40. North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2024-2033) & (US$ Million)
Table 41. Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2018-2023) & (US$ Million)
Table 42. Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2024-2033) & (US$ Million)
Table 43. Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2018-2023) & (US$ Million)
Table 44. Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2024-2033) & (US$ Million)
Table 45. Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 46. Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2018-2023) & (US$ Million)
Table 47. Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2024-2033) & (US$ Million)
Table 48. China Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2018-2023) & (US$ Million)
Table 49. China Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2024-2033) & (US$ Million)
Table 50. China Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2018-2023) & (US$ Million)
Table 51. China Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2024-2033) & (US$ Million)
Table 52. Asia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2018-2023) & (US$ Million)
Table 53. Asia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2024-2033) & (US$ Million)
Table 54. Asia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2018-2023) & (US$ Million)
Table 55. Asia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2024-2033) & (US$ Million)
Table 56. Asia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 57. Asia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Region (2018-2023) & (US$ Million)
Table 58. Asia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Region (2024-2033) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2018-2023) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2024-2033) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2018-2023) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2024-2033) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 64. Middle East, Africa, and Latin America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2018-2023) & (US$ Million)
Table 65. Middle East, Africa, and Latin America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2024-2033) & (US$ Million)
Table 66. Roche (Genentech) Company Details
Table 67. Roche (Genentech) Business Overview
Table 68. Roche (Genentech) Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product
Table 69. Roche (Genentech) Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2018-2023) & (US$ Million)
Table 70. Roche (Genentech) Recent Developments
Table 71. Amgen Company Details
Table 72. Amgen Business Overview
Table 73. Amgen Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product
Table 74. Amgen Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2018-2023) & (US$ Million)
Table 75. Amgen Recent Developments
Table 76. B-MS Company Details
Table 77. B-MS Business Overview
Table 78. B-MS Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product
Table 79. B-MS Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2018-2023) & (US$ Million)
Table 80. B-MS Recent Developments
Table 81. Merck Company Details
Table 82. Merck Business Overview
Table 83. Merck Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product
Table 84. Merck Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2018-2023) & (US$ Million)
Table 85. Merck Recent Developments
Table 86. Pfizer Company Details
Table 87. Pfizer Business Overview
Table 88. Pfizer Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product
Table 89. Pfizer Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2018-2023) & (US$ Million)
Table 90. Pfizer Recent Developments
Table 91. Novartis Company Details
Table 92. Novartis Business Overview
Table 93. Novartis Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product
Table 94. Novartis Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2018-2023) & (US$ Million)
Table 95. Novartis Recent Developments
Table 96. Eli Lilly and Company Company Details
Table 97. Eli Lilly and Company Business Overview
Table 98. Eli Lilly and Company Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product
Table 99. Eli Lilly and Company Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2018-2023) & (US$ Million)
Table 100. Eli Lilly and Company Recent Developments
Table 101. Johnson & Johnson Company Details
Table 102. Johnson & Johnson Business Overview
Table 103. Johnson & Johnson Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product
Table 104. Johnson & Johnson Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2018-2023) & (US$ Million)
Table 105. Johnson & Johnson Recent Developments
Table 106. GSK Company Details
Table 107. GSK Business Overview
Table 108. GSK Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product
Table 109. GSK Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2018-2023) & (US$ Million)
Table 110. GSK Recent Developments
Table 111. Sanofi Company Details
Table 112. Sanofi Business Overview
Table 113. Sanofi Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product
Table 114. Sanofi Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2018-2023) & (US$ Million)
Table 115. Sanofi Recent Developments
Table 116. Boehringer Ingelheim Company Details
Table 117. Boehringer Ingelheim Business Overview
Table 118. Boehringer Ingelheim Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product
Table 119. Boehringer Ingelheim Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2018-2023) & (US$ Million)
Table 120. Boehringer Ingelheim Recent Developments
Table 121. Zhejiang Jiuzhou Pharmaceutical Company Details
Table 122. Zhejiang Jiuzhou Pharmaceutical Business Overview
Table 123. Zhejiang Jiuzhou Pharmaceutical Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product
Table 124. Zhejiang Jiuzhou Pharmaceutical Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2018-2023) & (US$ Million)
Table 125. Zhejiang Jiuzhou Pharmaceutical Recent Developments
Table 126. Research Programs/Design for This Report
Table 127. Key Data Information from Secondary Sources
Table 128. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth Rate by Type, 2018 VS 2022 VS 2033 (US$ Million)
Figure 2. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Type: 2022 VS 2033
Figure 3. Aspirin Features
Figure 4. Ibuprofen Features
Figure 5. Naproxen Features
Figure 6. Celecoxib Features
Figure 7. Others Features
Figure 8. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth Rate by Application, 2018 VS 2022 VS 2033 (US$ Million)
Figure 9. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Application: 2022 VS 2033
Figure 10. Drug Store Case Studies
Figure 11. Hospital Pharmacies Case Studies
Figure 12. Online Case Studies
Figure 13. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Report Years Considered
Figure 14. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 15. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 16. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Region: 2022 VS 2033
Figure 17. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Players in 2022
Figure 18. Global Top Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) as of 2022)
Figure 19. The Top 10 and 5 Players Market Share by Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue in 2022
Figure 20. North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Type (2018-2033)
Figure 22. North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Application (2018-2033)
Figure 23. North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Country (2018-2033)
Figure 24. United States Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. Canada Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY (2018-2033) & (US$ Million)
Figure 27. Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Type (2018-2033)
Figure 28. Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Application (2018-2033)
Figure 29. Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Country (2018-2033)
Figure 30. Germany Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. France Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. U.K. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Italy Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Russia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Nordic Countries Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. China Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY (2018-2033) & (US$ Million)
Figure 37. China Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Type (2018-2033)
Figure 38. China Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Application (2018-2033)
Figure 39. Asia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY (2018-2033) & (US$ Million)
Figure 40. Asia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Type (2018-2033)
Figure 41. Asia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Application (2018-2033)
Figure 42. Asia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Region (2018-2033)
Figure 43. Japan Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. South Korea Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. China Taiwan Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Southeast Asia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. India Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 48. Australia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 49. Middle East, Africa, and Latin America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY (2018-2033) & (US$ Million)
Figure 50. Middle East, Africa, and Latin America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Type (2018-2033)
Figure 51. Middle East, Africa, and Latin America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Application (2018-2033)
Figure 52. Middle East, Africa, and Latin America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Country (2018-2033)
Figure 53. Brazil Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 54. Mexico Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 55. Turkey Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 56. Saudi Arabia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 57. Israel Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 58. GCC Countries Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 59. Roche (Genentech) Revenue Growth Rate in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2018-2023)
Figure 60. Amgen Revenue Growth Rate in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2018-2023)
Figure 61. B-MS Revenue Growth Rate in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2018-2023)
Figure 62. Merck Revenue Growth Rate in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2018-2023)
Figure 63. Pfizer Revenue Growth Rate in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2018-2023)
Figure 64. Novartis Revenue Growth Rate in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2018-2023)
Figure 65. Eli Lilly and Company Revenue Growth Rate in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2018-2023)
Figure 66. Johnson & Johnson Revenue Growth Rate in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2018-2023)
Figure 67. GSK Revenue Growth Rate in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2018-2023)
Figure 68. Sanofi Revenue Growth Rate in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2018-2023)
Figure 69. Boehringer Ingelheim Revenue Growth Rate in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2018-2023)
Figure 70. Zhejiang Jiuzhou Pharmaceutical Revenue Growth Rate in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2018-2023)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed